Menactra
STN/BL: 125089
Proper Name: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Tradename: Menactra
Manufacturer: Sanofi Pasteur Inc
Indications:
- Active immunization of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
Product Information
Supporting Documents
- April 27, 2018 Approval Letter - Menactra
To revise the package insert labeling to include additional information in the ADVERSE EVENTS and WARNINGS AND PRECAUTIONS section. - Supporting Documents older than three years - Menactra